Sterling has been awarded runner-up in the Best Contract Research Organisation (CRO) category at the 8th Annual World ADC Awards.

Of the many companies nominated, a shortlist of five companies was evaluated based on service range, reliability, value, and uniqueness in the ADC market, recognizing the significant role that CRO’s have in speeding up drug discovery.

Judges recognized the achievements made by our dedicated ADC bioconjugation team at our Deeside facility in the support given to over 60 clients at various stages of the development process, which have enabled the progression of nine ADCs into clinical trials and one ADC to market approval.

Read the full release on Sterling’s website.